Table 2 Comparison of final diagnoses between the 1.7 group and the 1.1 group
Final diagnosis | 1.7 group (n = 99) | 1.1 group (n = 99) |
|---|---|---|
Malignancy (%) | 84 (84.8) | 82 (82.8) |
  Lung adenocarcinoma | 59 (59.6) | 62 (62.6) |
  Lung squamous cell carcinoma | 6 (6.1) | 5 (5.1) |
  Small cell lung cancer | 7 (7.1) | 2 (2.0) |
  Lung adenocarcinoma + squamous cell carcinoma | 1 (1.0) | 0 (0) |
  Other non-small cell lung cancer | 4 (4.0) | 7 (7.1) |
  Lymphoma | 0 (0) | 1 (1.0) |
  Invasive thymoma | 1 (1.0) | 0 (0) |
  Sarcoma | 1 (1.0) | 0 (0) |
  Esophageal cancer | 2 (2.0) | 0 (0) |
  Breast cancer | 2 (2.0) | 1 (1.0) |
  Hepatocellular carcinoma | 1 (1.0) | 1 (1.0) |
  Buccal cancer | 0 (0) | 1 (1.0) |
  Prostate cancer | 0 (0) | 1 (1.0) |
  Colon cancer | 0 (0) | 1 (1.0) |
Non-malignancy (%) | 15 (15.2) | 17 (17.2) |
  Mycobacterium tuberculosis | 5 (5.1) | 4 (4.0) |
  Non-tuberculous mycobacteria | 0 (0) | 3 (3.0) |
  Bacterial pneumonia | 3 (3.0) | 0 (0) |
  Fungal infection | 1 (1.0) | 2 (2.0) |
   Aspergillosis | 0 (0) | 1 (1.0) |
   Mucomycosis | 0 (0) | 1 (1.0) |
   Penicilliosis | 1 (1.0) | 0 (0) |
  Bronchiectasis | 1 (1.0) | 0 (0) |
  Cryptogenic organizing pneumonia | 2 (2.0) | 2 (2.0) |
  Radiation-induced fibrosis | 0 (0) | 1 (1.0) |
  Benign inflammation | 3 (3.0) | 5 (5.1) |